Sale of ordinary shares out of treasury

RNS Number : 3304J

The MedicX Fund Limited

16 December 2015

 



For immediate release

16 December 2015

MedicX Fund Limited

("MedicX Fund", "the Fund" or "the Company")

Sale of ordinary shares out of treasury

MedicX Fund Limited announces that earlier today, Wednesday 16 December 2015, it sold for cash 2,000,000 ordinary shares of no par value in the Company. The ordinary shares were sold out of treasury by the Company, at a price per share of 86.25 pence.

The net proceeds will be used in further pursuing the investment objectives of the Company.

Total voting rights

In accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, the total number of ordinary shares in the capital of the Company in issue following this transaction will be 370,125,306 (excluding treasury shares) each with one voting right. 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company, under the Disclosure and Transparency Rules. 

The Company also holds 24,126,876 Ordinary Shares in treasury. 

Shareholders should note that, further to the announcement made by the Company on 10 December in respect of the Company's scrip dividend scheme, a further 185,789 Ordinary Shares will be sold out of treasury by the Company on 31 December 2015 (the "Scrip Dividend Transaction").  Following the Scrip Dividend Transaction (and assuming that no further Ordinary Shares are sold from treasury before 31 December 2015), the Company is expected to have a total of 370,311,095 Ordinary Shares in issue (excluding Ordinary Shares held in treasury), each with a voting right and 23,941,087 Ordinary Shares in treasury.

- End -

For further information please contact:

MedicX Fund                                                                  [phone]

David Staples, Chairman

Octopus Healthcare Group                                               [phone]

Mike Adams, Chief Executive Officer

Canaccord                                                                     [phone]

Andrew Zychowski/Helen Goldsmith        

Buchanan                                                                      [phone]

Charles Ryland/Vicky Watkins

Information on MedicX Fund Limited

MedicX Fund Limited (the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 148 properties.

The Investment Adviser to the Company is Octopus Healthcare Adviser Ltd, which is authorised and regulated by the Financial Conduct Authority and is a subsidiary of the Octopus Healthcare Group.  The Octopus Healthcare Group is a specialist investor, developer and manager of healthcare properties with 38 people operating across the UK. 

The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website), nor the contents of any website accessible from hyperlinks within this announcement, are incorporated into, or forms part of, this announcement.

 

END

 

 

MSCGGGGUPUPAGMQ